WHO 필수 의약품 목록

package.lua 80번째 줄에서 Lua 오류: module 'Module:Namespace detect/data' not found. package.lua 80번째 줄에서 Lua 오류: module 'Module:Message box/localize' not found.

어린이를 위한 목록에 관해서는 WHO 어린이 필수 의약품 목록 문서를 보십시오.

WHO 필수 의약품 모델 목록(WHO Model List of Essential Medicines, EML^[1])은 세계보건기구 (WHO)가 발간하는 목록으로, 보건 시스템에서 가장 중요한 요구 사항을 충족시키기 위해 가장 효과적이고 안전한 것으로 간주되는 의약품이 포함되어 있다.^[2] 이 목록은 국가가 자체 필수의약품 목록을 개발하는 데 자주 사용된다.^[2] 2016년 기준^[update], 155개국 이상이 세계보건기구의 모델 목록을 기반으로 국가 필수의약품 목록을 작성했다.^[1] 여기에는 선진국과 개발도상국이 모두 포함된다.^[2]^[3]

이 목록은 핵심 품목과 보완 품목으로 나뉜다.^[4] 핵심 품목은 주요 건강 문제에 대해 가장 비용 효율적인 옵션으로 간주되며, 추가 의료 자원이 거의 없어도 사용할 수 있다.^[4] 보완 품목은 특별히 훈련된 의료 서비스 제공자 또는 진단 장비와 같은 추가 인프라가 필요하거나 비용 대비 편익 비율이 낮다.^[4] 약 25%의 품목이 보완 목록에 포함된다.^[5] 일부 의약품은 핵심 및 보완 목록에 모두 포함된다.^[6] 목록에 있는 대부분의 의약품은 제네릭 제품으로 제공되지만, 특허를 받고 있다고 해서 포함에 ㅂ재되지는 않는다.^[7]

첫 번째 목록은 1977년에 출판되었고 208개의 약물이 포함되었다.^[8]^[2]^[9] WHO는 2년마다 목록을 갱신한다.^[10] 2005년 14차 목록에는 306개의 약물이,^[11] 2015년 19차 목록에는 410개,^[10] 2017년 20차 목록에는 433개,^[12]^[13] 2019년 21차 목록에는 460개,^[14]^[15]^[16] 2021년 22차 목록에는 479개^[17]^[18]의 약물이 있다. 다양한 국가 목록에는 334개에서 580개 사이의 약물이 포함되어 있다.^[5]^[19] 필수 의약품 목록(EML)은 2023년 7월에 23번째 버전으로 갱신되었다. 이 목록에는 591개의 약물과 103개의 치료 등가물에 대한 1,200개의 권장 사항이 포함되어 있다.^[20]

12세 이하 어린이를 위한 별도의 목록인 WHO 어린이 필수 의약품 모델 목록(EMLc)은 2007년에 만들어져 9번째 판이 나왔다.^[10]^[21]^[22]^[23] 적절한 제형의 가용성 등 어린이의 요구를 체계적으로 고려하기 위해 만들어졌다.^[24]^[25] 어린이 목록에 있는 모든 약물이 주 목록에도 포함되어 있다.^[26] 목록과 참고 사항은 주 목록의 19번째 판에서 23번째 판을 기반으로 한다.^[4]^[12]^[14]^[17]^[27] 일부 의약품의 경우 임상 성능이 유사한 치료 대체제가 나열되어 있으며 국가 필수 의약품 목록에 고려 될 수 있다.^[17]^[18] 9차 어린이 필수 의약품 목록은 2023년 7월 갱신되었다.^[23]^[28]

α는 해당 약물이 보완 목록에 있음을 나타낸다.^[4]^[14]^[17]

마취제, 수술 전 의약품 및 의료용 가스[편집]

전신 마취제 및 산소[편집]

보완 목록:

에페드린^α^{[note 1]}

의료용 가스[편집]

산소^{[note 2]}

통증 및 완화 치료용 의약품[편집]

비오피오이드 및 비스테로이드성 항염증제 (NSAIMs)[편집]

A line drawing of a hexagon with two attachments — 아스피린의 화학 구조 골격 구조식

아세틸살리실산(아스피린)
이부프로펜^{[note 3]}
파라세타몰^{[note 4]} (아세트아미노펜)

오피오이드계 진통제[편집]

코데인
펜타닐^{[note 5]}
모르핀^{[note 6]}

보완 목록:

메타돈^α^{[note 7]}

완화 치료의 다른 일반적인 증상에 대한 의약품[편집]

아미트리프틸린
사이클리진
덱사메타손
디아제팜
도큐세이트 나트룸
플루옥세틴
할로페리돌
부틸스코폴라민브롬화물
히오스신
락툴로오즈
로페라미드
메토클로프라미드
미다졸람
온단세트론^{[note 8]}
센나

아나필락시스에 사용되는 항알레르기제 및 의약품[편집]

덱사메타손
에피네프린 (아드레날린)
히드로코르티손
로라타딘^{[note 9]}^{[note 10]}
프레드니솔론^{[note 11]}

해독제 및 중독에 사용되는 기타 물질[편집]

비특정[편집]

의료용 활성탄

특정[편집]

아세틸시스테인
아트로핀
글루콘산 칼슘
염화 메틸티오니늄 (메틸렌 블루)
날록손
페니실라민
프러시안 블루
아질산 나트륨
싸이오황산 나트륨

보완 목록:

데페록사민^α
디메르카프롤^α
포메피졸^α
EDTA 칼슘 나트륨^α
디메르캅도숙신산^α

신경계 질환용 의약품[편집]

항경련제[편집]

카르바마제핀
디아제팜
라모트리진^{[note 12]}
레비티라세탐
로라제팜^{[note 13]}
황산 마그네슘^{[note 14]}
미다졸람^{[note 15]}
페노바르비탈
페니토인^{[note 16]}
발프로산 (발프로산 나트륨)^{[note 17]}

보완 목록:

에토석시미드^α
레비티라세탐^α
발프로산 (발프로산 나트륨)^α^{[note 17]}

다발성 경화증 치료제[편집]

보완 목록:

클라드리빈^α
글라티라머 아세테이트^α
리툭시맙^α^{[note 18]}

파킨슨병 치료제[편집]

비페리덴^{[note 19]}
레보도파/카르비도파 (레보도파 + 카르비도파)^{[note 20]}

항감염 의약품[편집]

구충제[편집]

장 구충제[편집]

A hexagon joined to a polygon with two attachments to this double ringed structure — 알벤다졸의 화학 구조 골격 구조식

알벤다졸
이버멕틴
레바미솔
메벤다졸
니클로사미드
프라지콴텔
피란텔

항사상충제[편집]

알벤다졸
디에틸카르바마진
이버멕틴

항주혈흡충제 및 기타 항선충제[편집]

프라지콴텔
트리클라벤다졸

보완 목록:

옥삼니퀸^α^{[note 21]}

살충 치료제[편집]

보완 목록:

알벤다졸^α
메벤다졸^α
프라지콴텔^α

항균제[편집]

접근 항생제[편집]

아미카신
아목시실린
아목시실린/클라불란산 (아목시실린 + 클라불란산)
암피실린
벤자틴 벤질페니실린
벤질페니실린
세팔렉신
세파졸린^{[note 22]}
클로람페니콜^{[note 23]}
클린다마이신
클록사실린^{[note 24]}^{[note 25]}
독시사이클린^{[note 26]}
겐타마이신
메트로니다졸
Nitrofurantoin
페녹시메틸 페니실린 (penicillin V)
Procaine benzylpenicillin^{[note 27]}
Spectinomycin
Sulfamethoxazole/trimethoprim (설파메톡사졸 + 트리메토프림)
트리메토프림

주의 항생제[편집]

아지트로마이신
세픽심
Cefotaxime^{[note 28]}
세프트리악손^{[note 29]}^{[note 30]}
Cefuroxime
시프로플록사신
클래리스로마이신^{[note 31]}^{[note 32]}
Piperacillin/tazobactam (piperacillin + tazobactam)
반코마이신^{[note 33]}

Complementary:

Ceftazidime^α
Meropenem^α^{[note 34]}
반코마이신^α

보류 항생제[편집]

Reserve antibiotics are last-resort antibiotics. The EML antibiotic book was published in 2022.^[29]^[30]^[31]

보완 목록:

Cefiderocol^α
Ceftazidime/avibactam (ceftazidime + avibactam)^α
Ceftolozane/tazobactam (ceftolozane + tazobactam)^α
콜리스틴^α
Fosfomycin^α
리네졸리드^α^{[note 35]}
Meropenem/vaborbactam (meropenem + vaborbactam)^α
Plazomicin^α
폴리믹신 B^α

한센병 치료제[편집]

클로파지민
댑손
리팜피신

결핵 치료제[편집]

에탐부톨
Ethambutol/isoniazid/pyrazinamide/rifampicin (에탐부톨 + 이소니아지드 + 피라진아마이드 + 리팜피신)
Ethambutol/isoniazid/rifampicin (에탐부톨 + 이소니아지드 + 리팜피신)
Ethionamide
이소니아지드
Isoniazid/pyrazinamide/rifampicin (이소니아지드 + 피라진아마이드 + 리팜피신)
Isoniazid/rifampicin (이소니아지드 + 리팜피신)
Isoniazid/rifapentine (이소니아지드 + rifapentine)
목시플록사신
피라진아마이드
리파부틴^{[note 36]}
리팜피신
Rifapentine

보완 목록:

아미카신^α
아목시실린/클라불란산 (아목시실린 + 클라불란산)^α^{[note 37]}
Bedaquiline^α
클로파지민^α
사이클로세린^α^{[note 38]}
Delamanid^α
Ethionamide^α^{[note 39]}
레보플록사신^α
리네졸리드^α
Meropenem^α^{[note 40]}
목시플록사신^α
P-aminosalicylic acid (p-aminosalicylate sodium)^α
프레토마니드^α
스트렙토마이신^α

항진균제[편집]

암포테리신 B
클로트리마졸
플루코나졸
Flucytosine
Griseofulvin
이트라코나졸^{[note 41]}
니스타틴
Voriconazole^{[note 42]}

보완 목록:

Micafungin^α^{[note 43]}
아이오딘화 칼륨^α

항바이러스 의약품[편집]

헤르페스 치료제[편집]

아시클로버^{[note 44]}

항레트로바이러스제[편집]

뉴클레오사이드/뉴클레오타이드 역전사 효소 억제제[편집]

아바카비르
라미부딘
Tenofovir disoproxil fumarate^{[note 45]}
지도부딘

비뉴클레오사이드 역전사 효소 억제제[편집]

에파비렌즈
네비라핀^{[note 46]}

단백질 분해 효소 억제제[편집]

Atazanavir/ritonavir (아타자나비르 + 리토나비르)
다루나비르^{[note 47]}
로피나비르/리토나비르 (로피나비르 + 리토나비르)
리토나비르

통합 효소 억제제[편집]

돌루테그라비르
랄테그라빌^{[note 48]}

항레트로바이러스제의 고정 용량 조합[편집]

아바카비르/라미부딘 (아바카비르 + 라미부딘)
돌루테그라비르/라미부딘/테노포비르 (돌루테그라비르 + 라미부딘 + 테노포비르)
에파비렌즈/엠트리시타빈/테노포비르^{[note 49]}
에파비렌즈/라미부딘/테노포비르 (에파비렌즈 + 라미부딘 + 테노포비르)
엠트리시타빈/테노포비르 (엠트리시타빈 + tenofovir)^{[note 49]}^{[note 50]}
라미부딘/지도부딘 (라미부딘 + 지도부딘)

HIV 관련 기회 감염 예방을 위한 의약품[편집]

이소니아지드/피리독신/설파메톡사졸/트리메토프림 (이소니아지드 + 피리독신 + 설파메톡사졸 + 트리메토프림)

기타 항바이러스제[편집]

리바비린^{[note 51]}
Valganciclovir^{[note 52]}

보완 목록:

오셀타미비르^α^{[note 53]}
Valganciclovir^α^{[note 54]}

간염 치료제[편집]

B형 간염 치료제[편집]

뉴클레오사이드/뉴클레오타이드 역전사 효소 억제제[편집]

Entecavir
Tenofovir disoproxil fumarate

C형 간염 치료제[편집]

Pangenotypic direct-acting antiviral combinations[편집]

Daclatasvir^{[note 55]}
Daclatasvir/sofosbuvir (daclatasvir + sofosbuvir)
Glecaprevir/pibrentasvir (glecaprevir + pibrentasvir)
Ravidasvir^{[note 56]}
Sofosbuvir^{[note 57]}
Sofosbuvir/velpatasvir (sofosbuvir + velpatasvir)

Non-pangenotypic direct-acting antiviral combinations[편집]

Ledipasvir/sofosbuvir (레디파스비르 + sofosbuvir)

기타 C형 간염 항바이러스제[편집]

리바비린^{[note 58]}

항원충제 의약품[편집]

Antiamoebic and antigiardiasis medicines[편집]

Diloxanide^{[note 59]}
메트로니다졸^{[note 60]}

Antileishmaniasis medicines[편집]

암포테리신 B^{[note 61]}
Meglumine antimoniate
Miltefosine
Paromomycin
Sodium stibogluconate

말라리아 치료제[편집]

For curative treatment[편집]

Amodiaquine^{[note 62]}
Artemether^{[note 63]}
Artemether/lumefantrine (artemether + lumefantrine)^{[note 64]}
Artesunate^{[note 65]}
Artesunate/amodiaquine (artesunate + amodiaquine)^{[note 66]}
Artesunate/mefloquine (artesunate + 메플로퀸)
Artesunate/pyronaridine tetraphosphate (artesunate + pyronaridine tetraphosphate)^{[note 67]}
클로로퀸^{[note 68]}
Dihydroartemisinin/piperaquine phosphate (dihydroartemisinin + piperaquine phosphate)^{[note 69]}
독시사이클린^{[note 70]}
메플로퀸^{[note 62]}
Primaquine^{[note 71]}
퀴닌^{[note 72]}
Sulfadoxine/pyrimethamine (sulfadoxine + pyrimethamine)^{[note 73]}

For chemoprevention[편집]

Amodiaquine + sulfadoxine/pyrimethamine (Co-packaged)
클로로퀸^{[note 74]}
독시사이클린^{[note 75]}
메플로퀸^{[note 76]}
Proguanil^{[note 77]}
Sulfadoxine/pyrimethamine (sulfadoxine + pyrimethamine)

Antipneumocystosis and antitoxoplasmosis medicines[편집]

Pyrimethamine
Sulfadiazine
Sulfamethoxazole/trimethoprim (설파메톡사졸 + 트리메토프림)

Complementary:

Pentamidine^α

Antitrypanosomal medicines[편집]

African trypanosomiasis[편집]

Fexinidazole^{[note 78]}

Medicines for the treatment of 1st stage African trypanosomiasis[편집]

Pentamidine^{[note 79]}
Suramin sodium^{[note 80]}

Medicines for the treatment of 2nd stage African trypanosomiasis[편집]

Eflornithine^{[note 81]}
Melarsoprol
Nifurtimox^{[note 82]}

보완 목록:

Melarsoprol^α

American trypanosomiasis[편집]

Benznidazole
Nifurtimox

Medicines for ectoparasitic infections[편집]

이버멕틴

Medicines for Ebola virus disease[편집]

Ansuvimab
Atoltivimab/maftivimab/odesivimab (atoltivimab + maftivimab + odesivimab)

코로나19 치료제[편집]

이 문단에는 목록이 없습니다.

편두통 치료제[편집]

급성 발작 치료용[편집]

아세트살리실산(아스피린)
이부프로펜
아세트아미노펜 (acetaminophen)^{[note 83]}
수마트립탄

For prophylaxis[편집]

프로프라놀롤

Immunomodulators and antineoplastics[편집]

Immunomodulators for non-malignant disease[편집]

Complementary:

아달리무맙^α^{[note 84]}
아자티오프린^α
시클로스포린^α
Tacrolimus^α

Antineoplastics and supportive medicines[편집]

Cytotoxic medicines[편집]

Complementary:

삼산화 이비소^α
Asparaginase^α^{[note 18]}
Bendamustine^α
블레오마이신^α
Calcium folinate (leucovorin calcium)^α
카페시타빈^α
카보플라틴^α
Chlorambucil^α
시스플라틴^α
시클로포스파미드^α
Cytarabine^α
다카바진^α
닥티노마이신^α
다우노루비신^α
Docetaxel^α
독소루비신^α
독소루비신 (as pegylated liposomal)^α
에토포시드^α
Fludarabine^α
플루오로유라실^α
젬시타빈^α
하이드록시카바마이드 (hydroxyurea)^α
Ifosfamide^α
Irinotecan^α
Melphalan^α
Mercaptopurine^α
메토트렉세이트^α
옥살리플라틴^α
파클리탁셀^α
Pegaspargase^α^{[note 18]}
Procarbazine^α
Realgar Indigo naturalis formulation^α
Tioguanine^α
빈블라스틴^α
빈크리스틴^α
비노렐빈^α

Targeted therapies[편집]

Complementary:

All-trans retinoic acid (tretinoin) (ATRA)^α
Bortezomib^α
Dasatinib^α
Erlotinib^α^{[note 85]}
Everolimus^α
Ibrutinib^α
이마티닙^α
Nilotinib^α
리툭시맙^α^{[note 18]}
트라스투주맙^α^{[note 18]}

Immunomodulators[편집]

Complementary:

필그라스팀^α^{[note 18]}
Lenalidomide^α
옵디보^α^{[note 86]}
Pegfilgrastim^α^{[note 18]}
탈리도마이드^α

Hormones and antihormones[편집]

Complementary:

Abiraterone^α^{[note 87]}
Anastrozole^α^{[note 88]}
Bicalutamide^α^{[note 89]}
덱사메타손^α
히드로코르티손^α
류프로렐린^α^{[note 90]}
Methylprednisolone^α
프레드니솔론^α^{[note 91]}
타목시펜^α

Supportive medicines[편집]

Complementary:

알로퓨리놀^α
Mesna^α
Rasburicase^α
Zoledronic acid^α

Therapeutic foods[편집]

Ready-to-use therapeutic food^{[note 92]}

Medicines affecting the blood[편집]

Antianaemia medicines[편집]

Ferrous salt
Ferrous salt/folic acid (ferrous salt + folic acid)
Folic acid^{[note 93]}
Hydroxocobalamin

Complementary:

Erythropoiesis-stimulating agents^α^{[note 94]}

Medicines affecting coagulation[편집]

Dabigatran^{[note 95]}
Enoxaparin^{[note 96]}
Heparin sodium
필로퀴논
Protamine sulfate
Tranexamic acid
와파린

Complementary:

Desmopressin^α
Heparin sodium^α
Protamine sulfate^α
와파린^α

Other medicines for haemoglobinopathies[편집]

Deferasirox^{[note 97]}

Complementary:

데페록사민^α
하이드록시카바마이드 (hydroxyurea)^α

Blood products of human origin and plasma substitutes[편집]

Blood and blood components[편집]

A straw colored liquid inside a clear plastic bag — Bag containing one unit of fresh frozen plasma

Cryoprecipitate, pathogen-reduced^{[note 98]}
Fresh frozen plasma
Platelets
Red blood cells
Whole blood

Plasma-derived medicines[편집]

Human immunoglobulins[편집]

Rho(D) immune globulin (anti-D immunoglobulin)
Anti-rabies immunoglobulin
Anti-tetanus immunoglobulin

Complementary:

Normal immunoglobulin^α

Blood coagulation factors[편집]

Complementary:

Coagulation factor VIII^α
Coagulation factor IX^α^{[note 99]}

Plasma substitutes[편집]

Dextran 70^{[note 100]}

Cardiovascular medicines[편집]

Antianginal medicines[편집]

비소프롤롤^{[note 101]}
Glyceryl trinitrate
Isosorbide dinitrate
Verapamil

Antiarrhythmic medicines[편집]

비소프롤롤^{[note 101]}
디곡신
Epinephrine (adrenaline)
리도카인
Verapamil

Complementary:

아미오다론^α

Antihypertensive medicines[편집]

암로디핀^{[note 102]}
비소프롤롤^{[note 103]}
에날라프릴^{[note 104]}
Hydralazine^{[note 105]}
히드로클로로티아지드^{[note 106]}
Lisinopril/amlodipine (lisinopril + 암로디핀)^{[note 107]}
Lisinopril/hydrochlorothiazide (lisinopril + 히드로클로로티아지드)^{[note 108]}
로자탄^{[note 109]}
Methyldopa^{[note 110]}
Telmisartan/amlodipine (telmisartan + 암로디핀)^{[note 111]}
Telmisartan/hydrochlorothiazide (telmisartan + 히드로클로로티아지드)^{[note 112]}

Complementary:

Sodium nitroprusside^α

Medicines used in heart failure[편집]

비소프롤롤^{[note 101]}
디곡신
에날라프릴^{[note 113]}
푸로세미드^{[note 114]}
히드로클로로티아지드^{[note 106]}
로자탄^{[note 109]}
스피로놀락톤

Complementary:

디곡신^α
Dopamine^α

Antithrombotic medicines[편집]

Anti-platelet medicines[편집]

Acetylsalicylic acid (aspirin)
클로피도그렐

Thrombolytic medicines[편집]

Complementary:

Alteplase^α
Streptokinase^α

Lipid-lowering agents[편집]

심바스타틴^{[note 115]}

Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease[편집]

Acetylsalicylic acid/atorvastatin/ramipril (acetylsalicylic acid + 아토바스타틴 + ramipril)^{[note 116]}^{[note 117]}
Acetylsalicylic acid/simvastatin/ramipril/atenolol/hydrochlorothiazide (acetylsalicylic acid + 심바스타틴 + ramipril + 아테놀올 + 히드로클로로티아지드)^{[note 118]}^{[note 117]}^{[note 119]}^{[note 120]}
Atorvastatin/perindopril/amlodipine (아토바스타틴 + perindopril + 암로디핀)^{[note 116]}^{[note 121]}^{[note 122]}

Dermatological medicines (topical)[편집]

Antifungal medicines[편집]

Miconazole^{[note 123]}
Selenium sulfide
Sodium thiosulfate
테르비나핀

Anti-infective medicines[편집]

무피로신
Potassium permanganate
Silver sulfadiazine

Anti-inflammatory and antipruritic medicines[편집]

Betamethasone^{[note 124]}
Calamine
히드로코르티손^{[note 125]}

Medicines affecting skin differentiation and proliferation[편집]

Benzoyl peroxide
Calcipotriol^{[note 126]}
콜타르
플루오로유라실
Podophyllum resin^{[note 127]}
Salicylic acid
Urea

Complementary:

메토트렉세이트^α

Scabicides and pediculicides[편집]

Benzyl benzoate^{[note 128]}
Permethrin

Diagnostic agents[편집]

Ophthalmic medicines[편집]

Fluorescein
Tropicamide^{[note 129]}

Radiocontrast media[편집]

Amidotrizoate
Barium sulfate
Iohexol

Complementary:

Barium sulfate^α
Meglumine iotroxate^α

Antiseptics and disinfectants[편집]

Antiseptics[편집]

클로르헥시딘
Ethanol^{[note 130]}
Povidone iodine^{[note 131]}

Disinfectants[편집]

Alcohol based hand rub
Chlorine base compound
Chloroxylenol^{[note 132]}
Glutaral

Diuretics[편집]

Amiloride
푸로세미드^{[note 133]}
히드로클로로티아지드^{[note 106]}
만니톨
스피로놀락톤

Complementary:

히드로클로로티아지드^α^{[note 134]}
만니톨^α
스피로놀락톤^α

Gastrointestinal medicines[편집]

Complementary:

Pancreatic enzymes^α

Antiulcer medicines[편집]

오메프라졸^{[note 135]}
라니티딘^{[note 136]}

Antiemetic medicines[편집]

덱사메타손
메토클로프라미드
온단세트론^{[note 8]}

Complementary:

아프레피탄트^α

Anti-inflammatory medicines[편집]

Sulfasalazine^{[note 137]}

Complementary:

히드로코르티손^α
프레드니솔론^α

Laxatives[편집]

Senna^{[note 138]}

Medicines used in diarrhoea[편집]

Oral rehydration salts + zinc sulfate (Co-packaged)

Oral rehydration[편집]

Oral rehydration salts

Medicines for diarrhoea[편집]

Zinc sulfate^{[note 139]}

Medicines for endocrine disorders[편집]

Adrenal hormones and synthetic substitutes[편집]

Fludrocortisone
히드로코르티손

Androgens[편집]

Complementary:

Testosterone^α

Estrogens[편집]

No listings in this section.

Progestogens[편집]

Medroxyprogesterone acetate^{[note 140]}

Medicines for diabetes[편집]

Insulins[편집]

Insulin injection (soluble)^{[note 18]}
Intermediate-acting insulin^{[note 18]}
Long-acting insulin analogues^{[note 141]}

Oral hypoglycaemic agents[편집]

Empagliflozin^{[note 142]}
Gliclazide^{[note 143]}
메트포르민

Complementary:

메트포르민^α

Medicines for hypoglycaemia[편집]

Glucagon

Complementary:

Diazoxide^α

Thyroid hormones and antithyroid medicines[편집]

Levothyroxine
아이오딘화 칼륨
Methimazole^{[note 144]}
프로필티오우라실^{[note 145]}

Complementary:

Lugol's solution^α
Methimazole^α^{[note 144]}
아이오딘화 칼륨^α
프로필티오우라실^α^{[note 146]}

Medicines for disorders of the pituitary hormone system[편집]

Cabergoline^{[note 147]}

Complementary:

옥트레오티드^α

Immunologicals[편집]

Diagnostic agents[편집]

투베르쿨린, purified protein derivative (PPD)

Sera, immunoglobulins and monoclonal antibodies[편집]

Anti-rabies virus monoclonal antibodies^{[note 18]}
Antivenom immunoglobulin^{[note 148]}
디프테리아 항독소
Equine rabies immunoglobulin

Vaccines[편집]

Recommendations for all

BCG vaccine
디프테리아 백신
Haemophilus influenzae type b vaccine
B형 간염 백신
Human papilloma virus (HPV) vaccine
홍역 백신
백일해 백신
폐렴구균 백신
Poliomyelitis vaccine
로타바이러스 백신
Rubella vaccine
파상풍 백신

Recommendations for certain regions

일본뇌염 백신^{[note 149]}
Tick-borne encephalitis vaccine^{[note 149]}
황열병 백신^{[note 149]}

Recommendations for some high-risk populations

콜레라 백신^{[note 150]}
뎅기열 백신^{[note 150]}
A형 간염 백신^{[note 150]}
Meningococcal meningitis vaccine^{[note 150]}
광견병 백신^{[note 150]}
장티푸스 백신^{[note 150]}

Recommendations for immunization programmes with certain characteristics

인플루엔자 백신 (seasonal)^{[note 151]}
볼거리 백신^{[note 151]}
수두 백신^{[note 151]}

Muscle relaxants (peripherally-acting) and cholinesterase inhibitors[편집]

Atracurium
네오스티그민
Suxamethonium
Vecuronium^{[note 152]}

Complementary:

Pyridostigmine^α
Vecuronium^α

Ophthalmological preparations[편집]

Anti-infective agents[편집]

아시클로버
아지트로마이신
에리트로마이신^{[note 153]}
겐타마이신^{[note 154]}
Natamycin
Ofloxacin^{[note 155]}
테트라사이클린^{[note 156]}

Anti-inflammatory agents[편집]

프레드니솔론

Local anesthetics[편집]

Tetracaine^{[note 157]}

Miotics and antiglaucoma medicines[편집]

아세타졸아마이드
Latanoprost
필로카핀^{[note 158]}
티모롤^{[note 159]}

Mydriatics[편집]

아트로핀^{[note 160]}

Complementary:

Epinephrine (adrenaline)^α

Anti-vascular endothelial growth factor (VEGF) preparations[편집]

Complementary:

베바시주맙^α^{[note 18]}

Medicines for reproductive health and perinatal care[편집]

Contraceptives[편집]

Oral hormonal contraceptives[편집]

Ethinylestradiol/levonorgestrel (에티닐에스트라다이올 + 레보노르게스트렐)
Ethinylestradiol/norethisterone (에티닐에스트라다이올 + norethisterone)
레보노르게스트렐
Ulipristal

Injectable hormonal contraceptives[편집]

Estradiol cypionate/medroxyprogesterone acetate (estradiol cypionate + medroxyprogesterone acetate)
Medroxyprogesterone acetate
Norethisterone enantate

Intrauterine devices[편집]

Copper-containing device
Levonorgestrel-releasing intrauterine system

Barrier methods[편집]

콘돔s
Diaphragms

Implantable contraceptives[편집]

Etonogestrel-releasing implant
Levonorgestrel-releasing implant

Intravaginal contraceptives[편집]

Ethinylestradiol/etonogestrel (에티닐에스트라다이올 + etonogestrel)
Progesterone vaginal ring^{[note 161]}

Ovulation inducers[편집]

Complementary:

Clomifene^α
Letrozole^α^{[note 162]}

Uterotonics[편집]

Carbetocin
Ergometrine^{[note 163]}
미페프리스톤 + misoprostol (Co-packaged)^{[note 164]}
Misoprostol^{[note 165]}
Oxytocin

Antioxytocics (tocolytics)[편집]

Nifedipine

Other medicines administered to the mother[편집]

덱사메타손
Multiple micronutrient supplement
Tranexamic acid

Medicines administered to the neonate[편집]

Caffeine citrate
클로르헥시딘

Complementary:

이부프로펜^α^{[note 166]}
Prostaglandin E1^α^{[note 167]}
Surfactant^α

Peritoneal dialysis solution[편집]

Complementary:

Intraperitoneal dialysis solution (of appropriate composition)^α

Medicines for mental and behavioural disorders[편집]

Medicines used in psychotic disorders[편집]

Fluphenazine^{[note 168]}
할로페리돌^{[note 169]}
올란자핀
팔리페리돈^{[note 170]}
리스페리돈^{[note 171]}

Complementary:

클로자핀^α

Medicines used in mood disorders[편집]

Medicines used in depressive disorders[편집]

아미트리프틸린
플루옥세틴^{[note 172]}

Medicines used in bipolar disorders[편집]

카르바마제핀
Lithium carbonate
쿠에티아핀^{[note 173]}
Valproic acid (sodium valproate)^{[note 17]}

Medicines for anxiety disorders[편집]

디아제팜^{[note 174]}^{[note 175]}
플루옥세틴^{[note 172]}

Medicines used for obsessive compulsive disorders[편집]

클로미프라민
플루옥세틴^{[note 172]}

Medicines for disorders due to psychoactive substance use[편집]

Medicines for alcohol use disorders[편집]

Acamprosate calcium
날트렉손

Medicines for nicotine use disorders[편집]

부프로피온
Nicotine replacement therapy (NRT)
바레니클린

Complementary:

메타돈^α^{[note 176]}

Medicines acting on the respiratory tract[편집]

Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease[편집]

Budesonide^{[note 177]}
부데소니드/포르모테롤 (budesonide + formoterol)^{[note 178]}
Epinephrine (adrenaline)
Ipratropium bromide
살부타몰^{[note 179]}
Tiotropium^{[note 180]}

Solutions correcting water, electrolyte and acid-base disturbances[편집]

Oral[편집]

Oral rehydration salts
Potassium chloride

Parenteral[편집]

Glucose
Glucose with sodium chloride
Potassium chloride
Sodium chloride
Sodium hydrogen carbonate
Sodium lactate, compound solution (Ringer's lactate solution)

Miscellaneous[편집]

Water for injection

Vitamins and minerals[편집]

Ascorbic acid
Calcium
Colecalciferol^{[note 181]}
에르고칼시페롤^{[note 182]}
Iodine
Multiple micronutrient powder
니코틴아마이드
피리독신
레티놀
리보플라빈
티아민

Complementary:

Calcium gluconate^α

Ear, nose and throat medicines[편집]

Acetic acid
Budesonide
시프로플록사신^{[note 183]}
Xylometazoline

Medicines for diseases of joints[편집]

Medicines used to treat gout[편집]

알로퓨리놀

Disease-modifying anti-rheumatic drugs (DMARDs)[편집]

클로로퀸

Complementary:

아자티오프린^α
하이드록시클로로퀸^α
메토트렉세이트^α
페니실라민^α
Sulfasalazine^α

Medicines for juvenile joint diseases[편집]

Complementary:

Acetylsalicylic acid (aspirin)^{[note 184]}
아달리무맙^α^{[note 84]}
메토트렉세이트^α
Triamcinolone hexacetonide^α^{[note 185]}

Dental medicines and preparations[편집]

Fluoride
글래스 아이오노머
Resin-based composite (low-viscosity)^{[note 186]}
Resin-based composite (high-viscosity)^{[note 187]}
Silver diamine fluoride

Notes[편집]

스크립트 오류: "anchor" 모듈이 없습니다.An α indicates the medicine is on the complementary list for which specialized diagnostic or monitoring or training is needed. An item may also be listed as complementary on the basis of higher costs or a less attractive cost-benefit ratio.^[4]^[14]

↑ (분만 중 척추 마취 시 저혈압을 예방하기 위해 사용한다).
↑ 임신 32주 미만의 신생아에게 소생술을 시작할 때 30% 이하의 산소를 사용해서는 안 된다.
↑ 3개월 미만의 어린이에게는 사용할 수 없다.
↑ 항염증 효과에 대한 입증된 효능이 없으므로 항염증제로 사용하지 않는 것이 좋다.
↑ 암 통증 관리용
↑ 하이드로모르폰과 옥시코돈이 대체 약물이다
↑ 암 통증 관리용.
↑ ^8.0 ^8.1 돌라세트론과 그라니세트론, 팔로노세트론, 트로피세트론이 대체 약물이다.
↑ 세티리진과 펙소페나딘이 대체 약물이다.
↑ 제한된 적응증에 대해 항히스타민제를 진정시키는 역할이 있을 수 있다(EMLc).
↑ 프레드니손이 대체 약물이다.
↑ 치료 저항성 부분 발작 또는 전신 발작에 대한 보조 요법으로 사용된다.
↑ 디아제팜과 미다졸람이 대체 약물이다.
↑ 자간증 및 중증 자간전증에 사용하며 다른 경련성 장애에는 사용하지 않는다.
↑ 구강 점막 투여용 용액을 사용할 수 없는 경우 협측 투여.
↑ 같은 시장에 25 mg/5 mL 및 30 mg/5 mL 농도가 모두 존재하면 처방 및 조제 시 혼란을 야기할 수 있으므로 피해야 한다.
↑ ^17.0 ^17.1 ^17.2 자궁에서 발프로산에 노출된 어린이의 선천적 결함 및 발달 장애 위험이 높기 때문에, 대체 치료법이 효과가 없거나 내약성이 없는 경우를 제외하고 임신 중 및 임신 가능한 여성과 소녀에게는 사용을 피해야 한다.
↑ ^18.00 ^18.01 ^18.02 ^18.03 ^18.04 ^18.05 ^18.06 ^18.07 ^18.08 ^18.09 ^18.10 Including quality-assured biosimilars
↑ 트라이헥시페니딜이 대체 약물이다.
↑ 벤세라자이드가 카르비도파의 대체 약물이다.
↑ 옥삼니퀸은 프라지콴텔 치료에 실패했을 때 사용할 수 있다.
↑ > 1 month.
↑ Only for the presumptive treatment of epidemic meningitis in children older than two years and in adults.
↑ Alternatives are 4th level ATC chemical subgroup (J01CF Beta-lactamase resistant penicillins)
↑ cloxacillin, dicloxacillin and flucloxacillin are preferred for oral administration due to better bioavailability.
↑ Use in children <8 years only for life-threatening infections when no alternative exists.
↑ Procaine benzylpenicillin is not recommended as first-line treatment for neonatal sepsis except in settings with high neonatal mortality, when given by trained health workers in cases where hospital care is not achievable.
↑ Third-generation cephalosporin of choice for use in hospitalized neonates.
↑ Do not administer with calcium and avoid in infants with hyperbilirubinemia.
↑ > 41 weeks corrected gestational age.
↑ 에리트로마이신 is an alternative as second choice treatment for pharyngitis in children (EMLc only)
↑ For use in combination regimens for eradication of H. pylori in adults.
↑ Vancomycin powder for injection may also be used for oral administration
↑ Imipenem/cilastatin is an alternative for complicated intraabdominal infections and high-risk febrile neutropenia only, except for acute bacterial meningitis in neonates, where meropenem is preferred
↑ Tedizolid phosphate is an alternative
↑ For use only in patients with HIV receiving protease inhibitors.
↑ For use only in combination with meropenem or imipenem/cilastatin.
↑ Terizidone is an alternative
↑ 프로치온아마이드 is an alternative
↑ Imipenem/cilastatin is an alternative
↑ For treatment of chronic pulmonary 아스페르길루스증, 히스토플라스마증, sporotrichosis, paracoccidioidomycosis, mycoses caused by Talaromyces marneffei and chromoblastomycosis; and prophylaxis of histoplasmosis and infections caused by Talaromyces marneffei in AIDS patients.
↑ For treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis.
↑ Anidulafungin and caspofungin are alternatives
↑ Valaciclovir is an alternative
↑ also indicated for pre-exposure prophylaxis.
↑ >6주
↑ > 3 years
↑ For use in pregnant women and in second-line regimens in accordance with WHO treatment guidelines.
↑ ^49.0 ^49.1 라미부딘 is an alternative for emtricitabine
↑ combination also indicated for pre-exposure prophylaxis
↑ For the treatment of viral haemorrhagic fevers
↑ For the treatment of 거대세포바이러스 retinitis (CMVr).
↑ For severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients
↑ For the treatment of cytomegalovirus retinitis (CMVr).
↑ Pangenotypic when used in combination with sofosbuvir
↑ Pangenotypic when used in combination with sofosbuvir
↑ Pangenotypic when used in combination with daclatasvir or ravidasvir
↑ For the treatment of hepatitis C, in combination with direct acting anti-viral medicines
↑ > 25 kg.
↑ Tinidazole is an alternative
↑ Liposomal amphotericin B has a better safety profile than the sodium deoxycholate formulation and should be prioritized for selection and use depending on local availability and cost.
↑ ^62.0 ^62.1 To be used in combination with artesunate 50 mg.
↑ For use in the management of severe malaria.
↑ Not recommended in the first trimester of pregnancy or in children below 5 kg.
↑ To be used in combination with either amodiaquine, 메플로퀸, or sulfadoxine + pyrimethamine.
↑ Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate are alternatives
↑ > 5 kg
↑ For use only for the treatment of Plasmodium vivax infection.
↑ > 5 kg
↑ For use only in combination with 퀴닌.
↑ Only for use to achieve radical cure of Plasmodium vivax and Plasmodium ovale infections, given for 14 days.
↑ For use only in the management of severe malaria, and should be used in combination with 독시사이클린.
↑ Only in combination with artesunate 50 mg.
↑ For use only in Central American regions, for Plasmodium vivax infections.
↑ > 8 years.
↑ > 5 kg or > 3 months.
↑ For use only in combination with 클로로퀸.
↑ For the treatment of 1st and 2nd stage human African trypanosomiasis due to Trypanosoma brucei gambiense infection.
↑ To be used for the treatment of Trypanosoma brucei gambiense infection.
↑ To be used for the treatment of the initial phase of Trypanosoma brucei rhodesiense infection.
↑ To be used for the treatment of Trypanosoma brucei gambiense infection
↑ Only to be used in combination with eflornithine, for the treatment of Trypanosoma brucei gambiense infection.
↑ The presence of both 120 mg/5 mL and 125 mg/5mL strengths on the same market would cause confusion in prescribing and dispensing and should be avoided.
↑ ^84.0 ^84.1 Certolizumab pegol, etanercept, golimumab and 인플릭시맵 are alternatives, including quality-assured 바이오시밀러s
↑ Afatinib and 게피티니브 are alternatives
↑ 키트루다 is an alternative, including quality-assured 바이오시밀러s
↑ Enzalutamide is an alternative
↑ Alternatives are 4th level ATC chemical subgroup (L02BG Aromatase inhibitors)
↑ Flutamide and nilutamide are alternatives
↑ Goserelin and triptorelin are alternatives
↑ Prednisone is an alternative
↑ Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines.
↑ periconceptual use for prevention of first occurrence of neural tube defects
↑ Epoetin alfa, beta and theta; darbepoetin alfa; methoxy polyethylene glycol-epoetin beta; and their quality-assured biosimilars are alternatives
↑ Apixaban, edoxaban, and rivaroxaban are alternatives
↑ Alternatives are dalteparin and nadroparin, including their quality-assured biosimilars.
↑ Deferiprone is an alternative
↑ cryoprecipitate (not pathogen-reduced) is an alternative
↑ coagulation factor IX complex is an alternative
↑ Polygeline, injectable solution, 3.5% is considered an alternative
↑ ^101.0 ^101.1 ^101.2 카베딜롤 and 메토프로롤 are alternatives
↑ Alternatives are 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives)
↑ Includes 아테놀올, 카베딜롤, and 메토프로롤 as alternatives. Atenolol should not be used as a first-line agent in uncomplicated hypertension in patients > 60 years.
↑ Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain)
↑ Hydralazine is listed for use only in the acute management of severe pregnancy-induced hypertension. Its use in the treatment of essential hypertension is not recommended in view of the evidence of greater efficacy and safety of other medicines.
↑ ^106.0 ^106.1 ^106.2 Chlorothiazide, chlorthalidone, and indapamide are alternatives
↑ Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) and 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)
↑ Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) and chlorthalidone, chlorothiazide, indapamide (for hydrochlorothiazide)
↑ ^109.0 ^109.1 Alternatives are 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain)
↑ Methyldopa is listed for use only in the management of pregnancy-induced hypertension. Its use in the treatment of essential hypertension is not recommended in view of the evidence of greater efficacy and safety of other medicines.
↑ Alternatives are 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) and 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)
↑ Alternatives are 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) and chlorthalidone, chlorothiazide, indapamide (for hydrochlorothiazide)
↑ Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain)
↑ Bumetanide and torasemide are alternatives
↑ For use in high‐risk patients. 아토바스타틴, fluvastatin, 로바스타틴, and pravastatin are alternatives
↑ ^116.0 ^116.1 fluvastatin, 로바스타틴, pravastatin, and 심바스타틴 are alternatives for atorvastatin
↑ ^117.0 ^117.1 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) are alternatives for ramipril
↑ 아토바스타틴, fluvastatin, 로바스타틴, and pravastatin are alternatives for simvastatin
↑ 비소프롤롤, 카베딜롤, and 메토프로롤 are alternatives for atenolol
↑ chlorthalidone, chlorothiazide, and indapamide are alternatives for hydrochlorothiazide
↑ 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) are alternatives for perindopril
↑ 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) are alternatives for amlodipine
↑ Alternatives are 4th level ATC chemical subgroup (D01AC Imidazole and triazole derivatives) excluding combinations
↑ Alternatives are 4th level ATC chemical subgroup (D07AC Corticosteroids, potent (group III))
↑ Alternatives are 4th level ATC chemical subgroup (D07AA Corticosteroids, weak (group I))
↑ 칼시트리올 and tacalcitol are alternatives
↑ Podophyllotoxin is an alternative
↑ precipitated sulfur topical ointment is an alternative
↑ 아트로핀 and cyclopentolate are alternatives
↑ 프로판올 is an alternative
↑ 아이오딘 is an alternative
↑ Alternatives are 4th level ATC chemical subgroup (D08AE Phenol and derivatives)
↑ Bumetanide and torasemide are alternatives
↑ Chlorothiazide and chlorthalidone are alternatives
↑ Alternatives are 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations
↑ Alternatives are 4th level ATC chemical subgroup (A02BA H2-receptor antagonists) excluding combinations
↑ 메살라진 is an alternative
↑ Bisacodyl is an alternative
↑ In acute diarrhoea zinc sulfate should be used as an adjunct to oral rehydration salts.
↑ Norethisterone is an alternative
↑ Insulin degludec, insulin detemir, and 인슐린 글라진, including quality-assured biosimilars are alternatives
↑ Canagliflozin and dapagliflozin are alternatives
↑ Glibenclamide not suitable above 60 years. Alternatives are 4th level ATC chemical subgroup (A10BB Sulfonylureas)
↑ ^144.0 ^144.1 Carbimazole is an alternative depending on local availability
↑ For use when alternative first-line treatment is not appropriate or available; and in patients during the first trimester of pregnancy.
↑ For use when alternative first-line treatment is not appropriate or available
↑ bromocriptine is an alternative
↑ Exact type to be defined locally
↑ ^149.0 ^149.1 ^149.2 Recommended for certain regions
↑ ^150.0 ^150.1 ^150.2 ^150.3 ^150.4 ^150.5 Recommended for some high-risk populations
↑ ^151.0 ^151.1 ^151.2 Recommended only for immunization programmes with certain characteristics
↑ atracurium is an alternative
↑ For infections due to Chlamydia trachomatis or Neisseria gonorrhoeae.
↑ 아미카신, kanamycin, netilmicin, and tobramycin are alternatives
↑ Alternatives are 4th level ATC chemical subgroup (S01AE Fluoroquinolones)
↑ Chlortetracycline and 옥시테트라사이클린 are alternatives
↑ Alternatives are 4th level ATC chemical subgroup (S01HA Local anaesthetics) excluding cocaine and combinations
↑ Carbachol is an alternative
↑ Alternatives are 4th level ATC chemical subgroup (S01ED Beta blocking agents) excluding combinations
↑ Cyclopentolate hydrochloride or homatropine hydrobromide are alternatives only for the EMLc
↑ For use in women actively breastfeeding at least 4 times per day
↑ anastrozole is an alternative
↑ Methylergometrine is an alternative
↑ Where permitted under national law and where culturally acceptable.
↑ Only for use for induction of labour where appropriate facilities are available.
↑ 인도메타신 is an alternative
↑ Prostaglandin E2 is an alternative
↑ haloperidol decanonate and zuclopenthixol decanonate are alternatives
↑ 클로르프로마진 is an alternative for the tablet
↑ 리스페리돈 injection is an alternative
↑ 아리피프라졸, 올란자핀, 팔리페리돈, and 쿠에티아핀 are alternatives
↑ ^172.0 ^172.1 ^172.2 시탈로프람, 에스시탈로프람, 플루복사민, 파록세틴, and 설트랄린 are alternatives
↑ 아리피프라졸, 올란자핀, and 팔리페리돈 are alternatives
↑ 로라제팜 is an alternative
↑ For short-term emergency management of acute and severe anxiety symptoms only
↑ 부프레노르핀 is an alternative. The medicines should only be used within an established support programme.
↑ Beclometasone, ciclesonide, flunisolide, 플루티카손, and mometasone are alternatives
↑ Beclometasone/formoterol, budesonide/salmeterol, fluticasone/formoterol, fluticasone furoate/vilanterol, and mometasone/formoterol are alternatives
↑ 터부탈린 is an alternative
↑ Aclidinium, glycopyrronium, and umeclidinium are alternatives
↑ 에르고칼시페롤 is an alternative
↑ Colecalciferol is an alternative
↑ Ofloxacin is an alternative
↑ For use for rheumatic fever, juvenile arthritis, Kawasaki disease
↑ triamcinolone acetonide is an alternative
↑ of any type for use as dental sealant
↑ of any type for use as dental filling material

References[편집]

↑ ^1.0 ^1.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ ^2.0 ^2.1 ^2.2 ^2.3 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "Citation/CS1" 모듈이 없습니다.
↑ ^4.0 ^4.1 ^4.2 ^4.3 ^4.4 ^4.5 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ ^5.0 ^5.1 스크립트 오류: "Citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "Citation/CS1" 모듈이 없습니다.
↑ ^10.0 ^10.1 ^10.2 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "Citation/CS1" 모듈이 없습니다.
↑ ^12.0 ^12.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ ^14.0 ^14.1 ^14.2 ^14.3 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ ^17.0 ^17.1 ^17.2 ^17.3 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ ^18.0 ^18.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ ^23.0 ^23.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "Citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.
↑ 스크립트 오류: "citation/CS1" 모듈이 없습니다.

External links[편집]

스크립트 오류: "URL" 모듈이 없습니다.

This article "WHO 필수 의약품 목록" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:WHO 필수 의약품 목록. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

Facebook Page

🐤 Twitter Follow us on Twitter !

Read or create/edit this page in another language[편집]

WHO 필수 의약품 목록 in English

[29] (분만 중 척추 마취 시 저혈압을 예방하기 위해 사용한다).

[30] 임신 32주 미만의 신생아에게 소생술을 시작할 때 30% 이하의 산소를 사용해서는 안 된다.

[31] 3개월 미만의 어린이에게는 사용할 수 없다.

[32] 항염증 효과에 대한 입증된 효능이 없으므로 항염증제로 사용하지 않는 것이 좋다.

[33] 암 통증 관리용

[34] 하이드로모르폰과 옥시코돈이 대체 약물이다

[35] 암 통증 관리용.

[ondansetron-36] 8.0 ^8.1 돌라세트론과 그라니세트론, 팔로노세트론, 트로피세트론이 대체 약물이다.

[37] 세티리진과 펙소페나딘이 대체 약물이다.

[38] 제한된 적응증에 대해 항히스타민제를 진정시키는 역할이 있을 수 있다(EMLc).

[39] 프레드니손이 대체 약물이다.

[40] 치료 저항성 부분 발작 또는 전신 발작에 대한 보조 요법으로 사용된다.

[41] 디아제팜과 미다졸람이 대체 약물이다.

[42] 자간증 및 중증 자간전증에 사용하며 다른 경련성 장애에는 사용하지 않는다.

[43] 구강 점막 투여용 용액을 사용할 수 없는 경우 협측 투여.

[44] 같은 시장에 25 mg/5 mL 및 30 mg/5 mL 농도가 모두 존재하면 처방 및 조제 시 혼란을 야기할 수 있으므로 피해야 한다.

[sodium_valproate-45] 17.0 ^17.1 ^17.2 자궁에서 발프로산에 노출된 어린이의 선천적 결함 및 발달 장애 위험이 높기 때문에, 대체 치료법이 효과가 없거나 내약성이 없는 경우를 제외하고 임신 중 및 임신 가능한 여성과 소녀에게는 사용을 피해야 한다.

[biosimilars-46] 18.00 ^18.01 ^18.02 ^18.03 ^18.04 ^18.05 ^18.06 ^18.07 ^18.08 ^18.09 ^18.10 Including quality-assured biosimilars

[47] 트라이헥시페니딜이 대체 약물이다.

[48] 벤세라자이드가 카르비도파의 대체 약물이다.

[49] 옥삼니퀸은 프라지콴텔 치료에 실패했을 때 사용할 수 있다.

[50] > 1 month.

[51] Only for the presumptive treatment of epidemic meningitis in children older than two years and in adults.

[52] Alternatives are 4th level ATC chemical subgroup (J01CF Beta-lactamase resistant penicillins)

[53] xacillin, dicloxacillin and flucloxacillin are preferred for oral administration due to better bioavailability.

[54] Use in children <8 years only for life-threatening infections when no alternative exists.

[55] Procaine benzylpenicillin is not recommended as first-line treatment for neonatal sepsis except in settings with high neonatal mortality, when given by trained health workers in cases where hospital care is not achievable.

[56] Third-generation cephalosporin of choice for use in hospitalized neonates.

[57] Do not administer with calcium and avoid in infants with hyperbilirubinemia.

[58] > 41 weeks corrected gestational age.

[59] 에리트로마이신 is an alternative as second choice treatment for pharyngitis in children (EMLc only)

[60] For use in combination regimens for eradication of H. pylori in adults.

[61] Vancomycin powder for injection may also be used for oral administration

[62] Imipenem/cilastatin is an alternative for complicated intraabdominal infections and high-risk febrile neutropenia only, except for acute bacterial meningitis in neonates, where meropenem is preferred

[66] Tedizolid phosphate is an alternative

[67] For use only in patients with HIV receiving protease inhibitors.

[68] For use only in combination with meropenem or imipenem/cilastatin.

[69] Terizidone is an alternative

[70] 프로치온아마이드 is an alternative

[71] Imipenem/cilastatin is an alternative

[72] For treatment of chronic pulmonary 아스페르길루스증, 히스토플라스마증, sporotrichosis, paracoccidioidomycosis, mycoses caused by Talaromyces marneffei and chromoblastomycosis; and prophylaxis of histoplasmosis and infections caused by Talaromyces marneffei in AIDS patients.

[73] For treatment of chronic pulmonary aspergillosis and acute invasive aspergillosis.

[74] Anidulafungin and caspofungin are alternatives

[75] Valaciclovir is an alternative

[76] so indicated for pre-exposure prophylaxis.

[77] >6주

[78] > 3 years

[79] For use in pregnant women and in second-line regimens in accordance with WHO treatment guidelines.

[lamivudine-80] 49.0 ^49.1 라미부딘 is an alternative for emtricitabine

[81] tion also indicated for pre-exposure prophylaxis

[82] For the treatment of viral haemorrhagic fevers

[83] For the treatment of 거대세포바이러스 retinitis (CMVr).

[84] For severe illness due to confirmed or suspected influenza virus infection in critically ill hospitalized patients

[85] For the treatment of cytomegalovirus retinitis (CMVr).

[86] Pangenotypic when used in combination with sofosbuvir

[87] Pangenotypic when used in combination with sofosbuvir

[88] Pangenotypic when used in combination with daclatasvir or ravidasvir

[89] For the treatment of hepatitis C, in combination with direct acting anti-viral medicines

[90] > 25 kg.

[91] Tinidazole is an alternative

[92] Liposomal amphotericin B has a better safety profile than the sodium deoxycholate formulation and should be prioritized for selection and use depending on local availability and cost.

[auto-93] 62.0 ^62.1 To be used in combination with artesunate 50 mg.

[94] For use in the management of severe malaria.

[95] Not recommended in the first trimester of pregnancy or in children below 5 kg.

[96] To be used in combination with either amodiaquine, 메플로퀸, or sulfadoxine + pyrimethamine.

[97] Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate are alternatives

[98] > 5 kg

[99] For use only for the treatment of Plasmodium vivax infection.

[100] > 5 kg

[101] For use only in combination with 퀴닌.

[102] Only for use to achieve radical cure of Plasmodium vivax and Plasmodium ovale infections, given for 14 days.

[103] For use only in the management of severe malaria, and should be used in combination with 독시사이클린.

[104] Only in combination with artesunate 50 mg.

[105] For use only in Central American regions, for Plasmodium vivax infections.

[106] > 8 years.

[107] > 5 kg or > 3 months.

[108] For use only in combination with 클로로퀸.

[109] For the treatment of 1st and 2nd stage human African trypanosomiasis due to Trypanosoma brucei gambiense infection.

[110] To be used for the treatment of Trypanosoma brucei gambiense infection.

[111] To be used for the treatment of the initial phase of Trypanosoma brucei rhodesiense infection.

[112] To be used for the treatment of Trypanosoma brucei gambiense infection

[113] Only to be used in combination with eflornithine, for the treatment of Trypanosoma brucei gambiense infection.

[114] The presence of both 120 mg/5 mL and 125 mg/5mL strengths on the same market would cause confusion in prescribing and dispensing and should be avoided.

[adalimumab-115] 84.0 ^84.1 Certolizumab pegol, etanercept, golimumab and 인플릭시맵 are alternatives, including quality-assured 바이오시밀러s

[116] Afatinib and 게피티니브 are alternatives

[117] 키트루다 is an alternative, including quality-assured 바이오시밀러s

[118] Enzalutamide is an alternative

[119] Alternatives are 4th level ATC chemical subgroup (L02BG Aromatase inhibitors)

[120] Flutamide and nilutamide are alternatives

[121] Goserelin and triptorelin are alternatives

[122] Prednisone is an alternative

[123] Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines.

[124] riconceptual use for prevention of first occurrence of neural tube defects

[125] Epoetin alfa, beta and theta; darbepoetin alfa; methoxy polyethylene glycol-epoetin beta; and their quality-assured biosimilars are alternatives

[126] Apixaban, edoxaban, and rivaroxaban are alternatives

[127] Alternatives are dalteparin and nadroparin, including their quality-assured biosimilars.

[128] Deferiprone is an alternative

[129] ryoprecipitate (not pathogen-reduced) is an alternative

[130] ulation factor IX complex is an alternative

[131] Polygeline, injectable solution, 3.5% is considered an alternative

[lolAlts-132] 101.0 ^101.1 ^101.2 카베딜롤 and 메토프로롤 are alternatives

[133] Alternatives are 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives)

[134] Includes 아테놀올, 카베딜롤, and 메토프로롤 as alternatives. Atenolol should not be used as a first-line agent in uncomplicated hypertension in patients > 60 years.

[135] Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain)

[136] Hydralazine is listed for use only in the acute management of severe pregnancy-induced hypertension. Its use in the treatment of essential hypertension is not recommended in view of the evidence of greater efficacy and safety of other medicines.

[hydrochlorothiazide-137] 106.0 ^106.1 ^106.2 Chlorothiazide, chlorthalidone, and indapamide are alternatives

[138] Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) and 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)

[139] Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) and chlorthalidone, chlorothiazide, indapamide (for hydrochlorothiazide)

[losartan-140] 109.0 ^109.1 Alternatives are 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain)

[141] Methyldopa is listed for use only in the management of pregnancy-induced hypertension. Its use in the treatment of essential hypertension is not recommended in view of the evidence of greater efficacy and safety of other medicines.

[142] Alternatives are 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) and 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)

[143] Alternatives are 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) and chlorthalidone, chlorothiazide, indapamide (for hydrochlorothiazide)

[144] Alternatives are 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain)

[145] Bumetanide and torasemide are alternatives

[146] For use in high‐risk patients. 아토바스타틴, fluvastatin, 로바스타틴, and pravastatin are alternatives

[atorvastatin-147] 116.0 ^116.1 fluvastatin, 로바스타틴, pravastatin, and 심바스타틴 are alternatives for atorvastatin

[ramipril-148] 117.0 ^117.1 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) are alternatives for ramipril

[149] 아토바스타틴, fluvastatin, 로바스타틴, and pravastatin are alternatives for simvastatin

[150] 비소프롤롤, 카베딜롤, and 메토프로롤 are alternatives for atenolol

[151] rthalidone, chlorothiazide, and indapamide are alternatives for hydrochlorothiazide

[152] 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) are alternatives for perindopril

[153] 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) are alternatives for amlodipine

[154] Alternatives are 4th level ATC chemical subgroup (D01AC Imidazole and triazole derivatives) excluding combinations

[155] Alternatives are 4th level ATC chemical subgroup (D07AC Corticosteroids, potent (group III))

[156] Alternatives are 4th level ATC chemical subgroup (D07AA Corticosteroids, weak (group I))

[157] 칼시트리올 and tacalcitol are alternatives

[158] Podophyllotoxin is an alternative

[159] recipitated sulfur topical ointment is an alternative

[160] 아트로핀 and cyclopentolate are alternatives

[161] 프로판올 is an alternative

[162] 아이오딘 is an alternative

[163] Alternatives are 4th level ATC chemical subgroup (D08AE Phenol and derivatives)

[164] Bumetanide and torasemide are alternatives

[165] Chlorothiazide and chlorthalidone are alternatives

[166] Alternatives are 4th level ATC chemical subgroup (A02BC Proton pump inhibitors) excluding combinations

[167] Alternatives are 4th level ATC chemical subgroup (A02BA H2-receptor antagonists) excluding combinations

[168] 메살라진 is an alternative

[169] Bisacodyl is an alternative

[170] In acute diarrhoea zinc sulfate should be used as an adjunct to oral rehydration salts.

[171] Norethisterone is an alternative

[172] Insulin degludec, insulin detemir, and 인슐린 글라진, including quality-assured biosimilars are alternatives

[173] Canagliflozin and dapagliflozin are alternatives

[174] Glibenclamide not suitable above 60 years. Alternatives are 4th level ATC chemical subgroup (A10BB Sulfonylureas)

[methimazole-175] 144.0 ^144.1 Carbimazole is an alternative depending on local availability

[176] For use when alternative first-line treatment is not appropriate or available; and in patients during the first trimester of pregnancy.

[177] For use when alternative first-line treatment is not appropriate or available

[178] romocriptine is an alternative

[179] Exact type to be defined locally

[regional-180] 149.0 ^149.1 ^149.2 Recommended for certain regions

[highrisk-181] 150.0 ^150.1 ^150.2 ^150.3 ^150.4 ^150.5 Recommended for some high-risk populations

[certainprogrammes-182] 151.0 ^151.1 ^151.2 Recommended only for immunization programmes with certain characteristics

[183] tracurium is an alternative

[184] For infections due to Chlamydia trachomatis or Neisseria gonorrhoeae.

[185] 아미카신, kanamycin, netilmicin, and tobramycin are alternatives

[186] Alternatives are 4th level ATC chemical subgroup (S01AE Fluoroquinolones)

[187] Chlortetracycline and 옥시테트라사이클린 are alternatives

[188] Alternatives are 4th level ATC chemical subgroup (S01HA Local anaesthetics) excluding cocaine and combinations

[189] Carbachol is an alternative

[190] Alternatives are 4th level ATC chemical subgroup (S01ED Beta blocking agents) excluding combinations

[191] Cyclopentolate hydrochloride or homatropine hydrobromide are alternatives only for the EMLc

[192] For use in women actively breastfeeding at least 4 times per day

[193] strozole is an alternative

[194] Methylergometrine is an alternative

[195] Where permitted under national law and where culturally acceptable.

[196] Only for use for induction of labour where appropriate facilities are available.

[197] 인도메타신 is an alternative

[198] Prostaglandin E2 is an alternative

[199] ridol decanonate and zuclopenthixol decanonate are alternatives

[200] 클로르프로마진 is an alternative for the tablet

[201] 리스페리돈 injection is an alternative

[202] 아리피프라졸, 올란자핀, 팔리페리돈, and 쿠에티아핀 are alternatives

[fluoxetine-203] 172.0 ^172.1 ^172.2 시탈로프람, 에스시탈로프람, 플루복사민, 파록세틴, and 설트랄린 are alternatives

[204] 아리피프라졸, 올란자핀, and 팔리페리돈 are alternatives

[205] 로라제팜 is an alternative

[206] For short-term emergency management of acute and severe anxiety symptoms only

[207] 부프레노르핀 is an alternative. The medicines should only be used within an established support programme.

[208] Beclometasone, ciclesonide, flunisolide, 플루티카손, and mometasone are alternatives

[209] Beclometasone/formoterol, budesonide/salmeterol, fluticasone/formoterol, fluticasone furoate/vilanterol, and mometasone/formoterol are alternatives

[210] 터부탈린 is an alternative

[211] Aclidinium, glycopyrronium, and umeclidinium are alternatives

[212] 에르고칼시페롤 is an alternative

[213] Colecalciferol is an alternative

[214] Ofloxacin is an alternative

[215] For use for rheumatic fever, juvenile arthritis, Kawasaki disease

[216] triamcinolone acetonide is an alternative

[217] y type for use as dental sealant

[218] y type for use as dental filling material

[EML-1] 1.0 ^1.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHO2017Def-2] 2.0 ^2.1 ^2.2 ^2.3 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[3] 스크립트 오류: "Citation/CS1" 모듈이 없습니다.

[WHO2015List-4] 4.0 ^4.1 ^4.2 ^4.3 ^4.4 ^4.5 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[Ban2013-5] 5.0 ^5.1 스크립트 오류: "Citation/CS1" 모듈이 없습니다.

[6] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[7] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[8] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[Lancet2017-9] 스크립트 오류: "Citation/CS1" 모듈이 없습니다.

[WHO2015Web-10] 10.0 ^10.1 ^10.2 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[11] 스크립트 오류: "Citation/CS1" 모듈이 없습니다.

[WHO201720th-12] 12.0 ^12.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[13] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHO21st-14] 14.0 ^14.1 ^14.2 ^14.3 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[15] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[16] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHO22nd-17] 17.0 ^17.1 ^17.2 ^17.3 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHO22nd_Executive_summary-18] 18.0 ^18.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[selection-19] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[20] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHO_2019_child-21] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHOEMLc8th-22] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[WHOEMLc9th-23] 23.0 ^23.1 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[24] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[25] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[26] 스크립트 오류: "Citation/CS1" 모듈이 없습니다.

[WHO23rd-27] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[28] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[63] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[64] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[65] 스크립트 오류: "citation/CS1" 모듈이 없습니다.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

α

[note 1]

[note 2]

[note 3]

[note 4]

[note 5]

[note 6]

[note 7]

[note 8]

[note 9]

[note 10]

[note 11]

[note 12]

[note 13]

[note 14]

[note 15]

[note 16]

[note 17]

[note 18]

[note 19]

[note 20]

[note 21]

[note 22]

[note 23]

[note 24]

[note 25]

[note 26]

[note 27]

[note 28]

[note 29]

[note 30]

[note 31]

[note 32]

[note 33]

[note 34]

[29]

[30]

[31]

[note 35]

[note 36]

[note 37]

[note 38]

[note 39]

[note 40]

[note 41]

[note 42]

[note 43]

[note 44]

[note 45]

[note 46]

[note 47]

[note 48]

[note 49]

[note 50]

[note 51]

[note 52]

[note 53]

[note 54]

[note 55]

[note 56]

[note 57]

[note 58]

[note 59]

[note 60]

[note 61]

[note 62]

[note 63]

[note 64]

[note 65]

[note 66]

[note 67]

[note 68]

WHO 필수 의약품 목록

마취제, 수술 전 의약품 및 의료용 가스[편집]

전신 마취제 및 산소[편집]

흡입형 의약품[편집]

주사형 의약품[편집]

국소 마취제[편집]

단기 시술을 위한 수술 전 약물 및 진정제 투여[편집]

의료용 가스[편집]

통증 및 완화 치료용 의약품[편집]

비오피오이드 및 비스테로이드성 항염증제 (NSAIMs)[편집]

오피오이드계 진통제[편집]

완화 치료의 다른 일반적인 증상에 대한 의약품[편집]

아나필락시스에 사용되는 항알레르기제 및 의약품[편집]

해독제 및 중독에 사용되는 기타 물질[편집]

비특정[편집]

특정[편집]

신경계 질환용 의약품[편집]

항경련제[편집]

다발성 경화증 치료제[편집]

파킨슨병 치료제[편집]

항감염 의약품[편집]

구충제[편집]

장 구충제[편집]

항사상충제[편집]

항주혈흡충제 및 기타 항선충제[편집]

살충 치료제[편집]

항균제[편집]

접근 항생제[편집]

주의 항생제[편집]

보류 항생제[편집]

한센병 치료제[편집]

결핵 치료제[편집]

항진균제[편집]

항바이러스 의약품[편집]

헤르페스 치료제[편집]

항레트로바이러스제[편집]

뉴클레오사이드/뉴클레오타이드 역전사 효소 억제제[편집]

비뉴클레오사이드 역전사 효소 억제제[편집]

단백질 분해 효소 억제제[편집]

통합 효소 억제제[편집]

항레트로바이러스제의 고정 용량 조합[편집]

HIV 관련 기회 감염 예방을 위한 의약품[편집]

기타 항바이러스제[편집]

간염 치료제[편집]

B형 간염 치료제[편집]

뉴클레오사이드/뉴클레오타이드 역전사 효소 억제제[편집]

C형 간염 치료제[편집]

Pangenotypic direct-acting antiviral combinations[편집]

Non-pangenotypic direct-acting antiviral combinations[편집]

기타 C형 간염 항바이러스제[편집]

항원충제 의약품[편집]

Antiamoebic and antigiardiasis medicines[편집]

Antileishmaniasis medicines[편집]

말라리아 치료제[편집]

For curative treatment[편집]

For chemoprevention[편집]

Antipneumocystosis and antitoxoplasmosis medicines[편집]

Antitrypanosomal medicines[편집]

African trypanosomiasis[편집]

Medicines for the treatment of 1st stage African trypanosomiasis[편집]

Medicines for the treatment of 2nd stage African trypanosomiasis[편집]

American trypanosomiasis[편집]

Medicines for ectoparasitic infections[편집]

Medicines for Ebola virus disease[편집]

코로나19 치료제[편집]

편두통 치료제[편집]

급성 발작 치료용[편집]

For prophylaxis[편집]

Immunomodulators and antineoplastics[편집]

Immunomodulators for non-malignant disease[편집]

Antineoplastics and supportive medicines[편집]

Cytotoxic medicines[편집]

Targeted therapies[편집]

Immunomodulators[편집]

Hormones and antihormones[편집]

Supportive medicines[편집]

Therapeutic foods[편집]

Medicines affecting the blood[편집]

Antianaemia medicines[편집]

Medicines affecting coagulation[편집]